PREDICTORS OF VENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH CORONARY HEART DISEASE AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

This review article is devoted to the identification of new predictors of the development of ventricular tachyarrhythmias (VA).The implantable cardioverter-defibrillator (ICD) in patients with the presence of risk factors is one of the main ways to prevent sudden cardiac death (SCD) due to VA. At the same time, data of 5 years of follow-up show that such kind of device is effective only in 15–25% of patients. For the reason that ICD implantation is associated with hospitalization and infection complications, there is a need to improve risk stratification and search for new prognostic markers of SCD and VA in order to reduce the number of inefficiently implanted ICDs and to reduce the costs of surgical intervention. In this regard, it is relevant to search for new predictors of VA development. In this field, it is promising to detect the disturbances of myocardial perfusion based on scintigraphy with thallium-199, to diagnose myocardial sympathetic innervation disorders by scintigraphy with iodine-131-labeled meta-iodine-benzylguanidine (MIBG), and to determine the levels of potential biochemical markers of myocardial fibrosis such as galectin-3 and ST2.

1. Lopera G., Huikuri H.V., Makikallio T.H. et al. Ishemic sudden death: critical analysis of risk markers // Rev. Esp. Cardiol. — 2010. — Vol. 53(4). — P. 568–574.

2. Zipes D., Camm A.J., Borggrefe M. et al. ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death-executive summary // J. Am. Coll. Cardiol. — 2006. — Vol. 48. — P. 1064–1108.

3. Priori S.G., Blomstrom-Lundqvist C., Mazzanti A. et al. Task force on sudden cardiac death of the European Society of Cardiology // Eur. Heart J. — 2001. — Vol. 22. — P. 1374–1450.

4. Бокерия О.Л., Биниашвили М.Б. Внезапная сердечная смерть и ишемическая болезнь сердца // Анн. аритмологии. — 2013. — № 10(2). — С. 69–79.

5. Carsten W.I. Mechanisms of sudden cardiac death // Indian Heart J. — 2014. — Vol. 66. — P. 10–17.

6. Рекомендации ESC по лечению пациентов с желудочковыми нарушениями ритма и профилактике внезапной сердечной смерти // Рос. кардиол. журн. — 2016. — № 7(135). — С. 5–86.

7. Lee M.S., Yang T., Dhoot J. et al. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowings // Am. J. Car-diol. — 2010. — Vol. 105(8). — P. 1070–1075.

8. Merchant F.M., Jones P., Wehrenberg S. et al. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life // J. Am. Heart Assoc. — 2014. — Vol. 3. — P. 1–7.

9. Chugh S.S., Reinier K. Determinants of prolonged Q-T interval and their contribution to sudden death risk in coronary artery disease: the Oregon sudden unexpected death study // Circulation. — 2009. — Vol. 119. — P. 663–670.

10. Чернова А.А., Никулина С.Ю., Третьякова С.С. и др. Генетические аспекты этиологии синдрома слабости синусового узла // Анн. аритмологии. — 2013. — № 10(1). — С. 15–22.

11. Scott P.A., Barry J., Roberts P.R. et al. Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: A meta-analysis // Eur. J. Heart Failure. — 2009. — Vol. 11. — P. 958–966.

12. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable car-dioverter defibrillator for secondary prophylaxis / Rolf S. [et al.] // Europace. — 2009 Mar. — Vol.11(3). — P. 289–296.

13. Moss A.J., Zareba W., Hall W.J. et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction // N. Engl. J. Med. — 2002. — Vol. 346. — P. 877–883

14. Громова О.И., Александрова С.А., Макаренко В.Н. и др. Современные предикторы жизнеугрожающих аритмий // Креат. кардиология. — 2012. — № 2. — С. 30–46.

15. Pfeffer M.A., John J.V., McMurray et al. Valsartan, Captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both // N. Engl. J. Med. — 2003. — Vol. 349. — P. 1893–1906.

16. Dorian P., Hohnloser S.H., Thorpe K.E. et al. Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the defibrillation in acute myocardial infarction trial (DINAMIT) // Circulation. — 2010. — Vol. 122(25). — P. 2645–2652.

17. Piccini J.P., Zhang M., Pieper K. et al. Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial // Eur. Heart J. — 2010. — Vol. 31. — P. 211–221.

18. Голухова Е.З. Внезапная сердечная смерть. Меняют ли результаты рандомизированных исследований наши представления о возможных предикторах и путях профилактики? // Креат. кардиол. — 2008. — № 1. — С. 7–24.

19. Tracy C.M., Epstein A.E., Darbar D. et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines // Circulation. — 2012. — Vol. 126. — P. 1–17.

20. Ghuran A., Reid F., La Rovere M.T. et al. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (the autonomic tone and reflexes after myocardial infarction substudy) // Am. J. Cardiol. — 2002. — Vol. 89(2). — P. 184–190.

21. Ikeda T., Yoshino H., Sugi K. et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study // J. Am. Coll. Cardiol. — 2006. — Vol. 48. — P. 2268–2274.

22. Costantini O., Hohnloser S.H., Kirk M.M. et al. The ABCD (Alter-nans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention // J. Am. Coll. Cardiol. — 2009. — Vol. 53. — P. 471–479.

23. Patton K.K., Sotoondehnia N., DeFilippi C. et al. N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the cardiovascular health study // Heart Rhythm. — 2011. — Vol. 8. — P. 228–233.

24. Kanoupakis E.M., Manios E.G., Kallergis E.M. et al. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment // J. Am. Coll. Cardiol. — 2010. — Vol. 55. — P. 2753–2759.

25. Mueller T., Dieplinger B. Soluble ST2 and galectin-3: what we know and don’t know analytically // EJIFCC. — 2016. — Vol. 27(3). — P. 224–237.

26. Dieplinger B., Mueller T. Soluble ST2 in heart failure // Clin. Chim. Acta. — 2015. — Vol. 443. — P. 57–70.

27. Hughes M.F., Appelbaum S., Havulinna A.S. et al. ST2 may not be useful predictor for incident cardiovascular events, heart failure and mortality // Heart. — 2014. — Vol. 100. — P. 1715–1721.

28. Bax J.J., Kraft O., Buxton A.E. et al. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study // Circ. Cardiovasc. Imaging. — 2008. — Vol. 1(2). — P. 131–140.

29. Nakajima K., Scholte A.J., Nakata T. et al. Cardiac sympathetic nervous system imaging with 123I-meta-iodobenzylguanidine: Perspectives from Japan and Europe // J. Nucl. Cardiol. — 2017. — P. 1–9.

30. Jacobson A.F., Senior R., Cerqueira M.D. et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study // J. Am. Coll. Cardiol. — 2010. — Vol. 55. — P. 2212–2221.

31. Boogers M.J., Borleffs C.J., Henneman M.M. et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients // J. Am. Coll. Cardiol. — 2010. — Vol. 55. — P. 2769–2777.

32. Hachamovitch R., Nutter B., Menon V. et al. Predicting risk versus predicting potential survival benefit using 123I-mIBG imaging in patients with systolic dysfunction eligible for implantable cardiac defibrillator implantation: analysis of data from the prospective ADMIREHF study // Circ. Cardiovasc. Imaging. — 2015. — Vol. 8(12). — P. 1–12.

33. Fujita K., Kasama S., Kurabayashi M. Serial dual single-photon emission computed tomography of thallium-201 and iodine-123 beta-methyliodophenyl pentadecanoic acid scintigraphy can predict functional recovery of patients with coronary artery disease after coronary artery bypass graft surgery // Nucl. Med. Commun. — 2015. — Vol. 36(2). — P. 148–155.

34. Henzlova M.J., Duvall W.L. Tl-201 dosing for CZT SPECT: More new information // J. Nucl. Cardiol. — 2017. — P. 1–3.

35. Kurisu S., Sumimoto Y., Ikenaqa H. et al. Comparison of 8-frame and 16-frame thallium-201 gated myocardial perfusion SPECT for determining left ventricular systolic and diastolic parameters // Heart Vessels. — 2016. — P. 1–6.

36. Mori H., Isobe S., Sakai S. et al. Microvascular obstruction on delayed enhancement cardiac magnetic resonance imaging after acute myocardial infarction, compared with myocardial (201) Tl and (123)I-BMIPP dual SPECT findings // Eur. J. Radiol. — 2015. — Vol. 84(8). — P. 1516–1524.

37. Hussein A.A., Niekoop M., Dilsizian V. et al. Hibernating substrate of ventricular tachycardia: a three-dimensional metabolic and electro-anatomic assessment // J. Interv. Card. Electrophysiol. — 2017 Apr. — Vol. 48(3). — P. 247–254.